Postoperative Pain Market

DelveInsight’s Postoperative Pain market report provides an in-depth understanding of Postoperative Pain, historical and forecasted epidemiology, and Postoperative Pain market trends in the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Some Key Highlights from the Postoperative Pain Market Report

• According to DelveInsight Postoperative Pain epidemiology insights, the total incident cases was estimated to be more than 60 million in 2020 in 7MM. 

• In 2020, Germany had the most cases of Postoperative Pain among the EU5, with over 4 million cases while Spain, on the other hand, had the lowest number of Postoperative Pain cases in 2020.

• According to DelveInsight, the Postoperative Pain severity-specific incident cases in the US for moderate cases was maximum, followed by mild  and severe cases in 2020.

• Korsuva (Cara Therapeutics), VVZ-149 (Vivozon Inc.), Tramadol IV (Avenue Therapeutics, Inc.), PRF-110 (PainReform LTD), F14/mdc-CWM (Celecoxib) (Arthritis Innovation Corporation/MedinCell), NVK-009 (Nevakar, Inc.), TLC590 (Taiwan Liposome Company (TLC)), MR-107A-01 (Viatris Inc.), TPU-006 (Teikoku Pharma USA, Inc.), SAF312 (Novartis Pharmaceuticals), OCS-01 (Oculis) and others are some of the pipeline therapies in the Postoperative Pain market.

• Vivozon Inc., Avenue Therapeutics, Inc., PainReform LTD, Arthritis Innovation Corporation/MedinCell, Nevakar, Inc., Taiwan Liposome Company (TLC), Viatris Inc., Teikoku Pharma USA, Inc., Novartis Pharmaceuticals, Oculis are among the notable companies which are proactively working towards the development of novel therapies in the Postoperative Pain market.

To get more insights, request sample @ Postoperative Pain Market Report

The Postoperative Pain market report covers current treatment practises, developing medications, individual therapies’ Postoperative Pain market share, and present and predicted Postoperative Pain market size from 2018 to 2030, segmented into seven major markets. The report also examines current Postoperative Pain treatment practices/algorithms, market drivers, market constraints, and unmet medical needs in order to identify and evaluate the market’s underlying potential.

Postoperative Pain: Overview

Postoperative Pain is a brief and expected increase in background pain that occurs following surgical treatment. It’s a sort of pain that lasts anywhere from a few days to months and is caused by soft tissue damage like a sprained ankle or a paper cut. The discomfort lasts only a few minutes, but it fades as the wounded tissues heal.

Postoperative Pain Epidemiology Segmentation

• Postoperative Pain Total Number of Surgical Procedures

• Postoperative Pain Total Incident Cases 

• Postoperative Pain Severity-Specific Incident Cases 

Postoperative Pain Treatment Landscape

Current major treatment options for Postoperative Pain are:

• NSAIDs

• Opioids 

• Anesthetics

• Others (e.g. Corticosteroids)

Postoperative Pain Market

• The Postoperative Pain market size in the 7MM might grow at a CAGR of 7.93%. 

• In the United States, the therapeutic market for Postoperative Pain was USD 2,223 million in 2020.

• Germany has the largest Postoperative Pain therapeutic market among the EU5 countries while Spain captured the smallest Postoperative Pain therapeutic market in 2020.

Get complete information on market @ Postoperative Pain Market Analysis

Postoperative Pain Pipeline Therapies and Key Companies 

• Korsuva: Cara Therapeutics

• VVZ-149: Vivozon Inc.

• Tramadol IV: Avenue Therapeutics, Inc.

• PRF-110: PainReform LTD

• F14/mdc-CWM (Celecoxib): Arthritis Innovation Corporation/MedinCell

• NVK-009: Nevakar, Inc.

• TLC590: Taiwan Liposome Company (TLC)

• MR-107A-01: Viatris Inc.

• TPU-006: Teikoku Pharma USA, Inc.

•  SAF312: Novartis Pharmaceuticals

• OCS-01: Oculis

Postoperative Pain Market Drivers

• Increased patient pool

• Multimodal therapeutic strategies

• Awareness of the disease

• Research and developmental strategies

Postoperative Pain Market Barriers 

• Knowledge and approach towards pain management

• Age-specific treatment (lacks for pediatric and children)

• Ignorance of pain

Scope for the Report

Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain and France) and Japan)

Study Period: 2018-30

Postoperative Pain Key Companies: Vivozon Inc., Avenue Therapeutics, Inc., PainReform LTD, Arthritis Innovation Corporation/MedinCell, Nevakar, Inc., Taiwan Liposome Company (TLC), Viatris Inc., Teikoku Pharma USA, Inc., Novartis Pharmaceuticals, Oculis, among others. 

Postoperative Pain Key Pipeline Therapies: VVZ-149 (Vivozon Inc.), Tramadol IV (Avenue Therapeutics, Inc.), PRF-110 (PainReform LTD), F14/mdc-CWM (Celecoxib) (Arthritis Innovation Corporation/MedinCell), NVK-009 (Nevakar, Inc.), TLC590 (Taiwan Liposome Company (TLC)), MR-107A-01 (Viatris Inc.), TPU-006 (Teikoku Pharma USA, Inc.), SAF312 (Novartis Pharmaceuticals), OCS-01 (Oculis), and others.

Postoperative Pain Segmentation: By Geography, By Postoperative Pain therapies

Analysis: Comparative and conjoint analysis of Postoperative Pain emerging therapies

Tools Used: SWOT Analysis

Case Studies

KOL’s Views

Analyst’s Views

Table of Contents

For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare and Biotech Blog Posts

Related Reports

Chronic Pain Market

Get comprehensive historical and forecast analysis of Chronic Pain Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Aptinyx, Samumed, Biogen, Allodynic Therapeutics, Bayer, MiMedx, Semnur Pharmaceuticals, Pfizer, Eli Lilly and Company, among others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/